Annual Retained Earnings
-$217.48 M
-$37.98 M-21.16%
December 31, 2023
Summary
- As of February 8, 2025, CLRB annual retained earnings is -$217.48 million, with the most recent change of -$37.98 million (-21.16%) on December 31, 2023.
- During the last 3 years, CLRB annual retained earnings has fallen by -$90.71 million (-71.55%).
- CLRB annual retained earnings is now -1312.35% below its all-time high of -$15.40 million, reached on December 31, 2005.
Performance
CLRB Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$244.99 M
-$14.66 M-6.37%
September 30, 2024
Summary
- As of February 8, 2025, CLRB quarterly retained earnings is -$244.99 million, with the most recent change of -$14.66 million (-6.37%) on September 30, 2024.
- Over the past year, CLRB quarterly retained earnings has dropped by -$42.23 million (-20.83%).
- CLRB quarterly retained earnings is now -189371.85% below its all-time high of -$129.30 thousand, reached on March 31, 2005.
Performance
CLRB Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
CLRB Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -21.2% | -20.8% |
| 3 y3 years | -71.5% | -69.0% |
| 5 y5 years | -122.9% | -126.2% |
CLRB Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -44.1% | at low | -62.4% | at low |
| 5 y | 5-year | -94.7% | at low | -119.4% | at low |
| alltime | all time | -1312.3% | at low | <-9999.0% | at low |
Cellectar Biosciences Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$244.99 M(+6.4%) |
| Jun 2024 | - | -$230.32 M(-3.7%) |
| Mar 2024 | - | -$239.06 M(+17.9%) |
| Dec 2023 | -$217.48 M(+21.2%) | -$202.76 M(-3.5%) |
| Sep 2023 | - | -$210.03 M(+7.0%) |
| Jun 2023 | - | -$196.30 M(+4.4%) |
| Mar 2023 | - | -$188.08 M(+17.6%) |
| Dec 2022 | -$179.50 M(+19.0%) | -$159.99 M(-7.1%) |
| Sep 2022 | - | -$172.28 M(+4.7%) |
| Jun 2022 | - | -$164.47 M(+4.7%) |
| Mar 2022 | - | -$157.04 M(+4.1%) |
| Dec 2021 | -$150.90 M(+19.0%) | -$150.90 M(+4.1%) |
| Sep 2021 | - | -$144.98 M(+4.2%) |
| Jun 2021 | - | -$139.16 M(+4.5%) |
| Mar 2021 | - | -$133.13 M(+5.0%) |
| Dec 2020 | -$126.78 M(+13.5%) | -$126.78 M(+2.9%) |
| Sep 2020 | - | -$123.16 M(+3.3%) |
| Jun 2020 | - | -$119.25 M(+3.1%) |
| Mar 2020 | - | -$115.64 M(+3.5%) |
| Dec 2019 | -$111.68 M(+14.4%) | -$111.68 M(+3.1%) |
| Sep 2019 | - | -$108.30 M(+3.7%) |
| Jun 2019 | - | -$104.40 M(+3.1%) |
| Mar 2019 | - | -$101.21 M(+3.7%) |
| Dec 2018 | -$97.59 M(+15.7%) | -$97.59 M(+4.1%) |
| Sep 2018 | - | -$93.76 M(+3.3%) |
| Jun 2018 | - | -$90.75 M(+3.3%) |
| Mar 2018 | - | -$87.83 M(+4.1%) |
| Dec 2017 | -$84.35 M(+19.2%) | -$84.35 M(+5.1%) |
| Sep 2017 | - | -$80.27 M(+4.5%) |
| Jun 2017 | - | -$76.80 M(+4.2%) |
| Mar 2017 | - | -$73.68 M(+4.1%) |
| Dec 2016 | -$70.79 M(+9.6%) | -$70.79 M(+3.8%) |
| Sep 2016 | - | -$68.20 M(+3.5%) |
| Jun 2016 | - | -$65.92 M(+3.3%) |
| Mar 2016 | - | -$63.78 M(-1.3%) |
| Dec 2015 | -$64.61 M(+9.3%) | -$64.61 M(-1.5%) |
| Sep 2015 | - | -$65.56 M(+2.9%) |
| Jun 2015 | - | -$63.70 M(+3.7%) |
| Mar 2015 | - | -$61.41 M(+3.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | -$59.11 M(+15.8%) | -$59.11 M(+4.4%) |
| Sep 2014 | - | -$56.59 M(+0.9%) |
| Jun 2014 | - | -$56.09 M(+3.9%) |
| Mar 2014 | - | -$54.00 M(+5.8%) |
| Dec 2013 | -$51.06 M(+26.8%) | -$51.06 M(+8.4%) |
| Sep 2013 | - | -$47.11 M(+2.9%) |
| Jun 2013 | - | -$45.80 M(+4.7%) |
| Mar 2013 | - | -$43.73 M(+8.6%) |
| Dec 2012 | -$40.28 M(+27.9%) | -$40.28 M(+5.7%) |
| Sep 2012 | - | -$38.12 M(+5.7%) |
| Jun 2012 | - | -$36.07 M(+6.6%) |
| Mar 2012 | - | -$33.84 M(+7.5%) |
| Dec 2011 | -$31.48 M(+30.9%) | -$31.48 M(+6.7%) |
| Sep 2011 | - | -$29.51 M(+6.9%) |
| Jun 2011 | - | -$27.61 M(-63.2%) |
| Mar 2011 | - | -$74.99 M(+211.9%) |
| Dec 2010 | -$24.05 M(-68.4%) | -$24.05 M(-67.2%) |
| Sep 2010 | - | -$73.38 M(+1.7%) |
| Jun 2010 | - | -$72.15 M(+2.0%) |
| Mar 2010 | - | -$70.72 M(-7.0%) |
| Dec 2009 | -$76.07 M(+27.4%) | -$76.07 M(+20.3%) |
| Sep 2009 | - | -$63.21 M(+4.5%) |
| Jun 2009 | - | -$60.47 M(+8.7%) |
| Mar 2009 | - | -$55.61 M(-6.8%) |
| Dec 2008 | -$59.69 M(+38.0%) | -$59.69 M(+3.7%) |
| Sep 2008 | - | -$57.55 M(+4.6%) |
| Jun 2008 | - | -$55.02 M(+9.3%) |
| Mar 2008 | - | -$50.34 M(+16.4%) |
| Dec 2007 | -$43.24 M(+82.6%) | -$43.24 M(+17.8%) |
| Sep 2007 | - | -$36.70 M(+21.2%) |
| Jun 2007 | - | -$30.29 M(+16.2%) |
| Mar 2007 | - | -$26.07 M(+10.1%) |
| Dec 2006 | -$23.68 M(+53.8%) | -$23.68 M(+12.7%) |
| Sep 2006 | - | -$21.01 M(+15.4%) |
| Jun 2006 | - | -$18.21 M(+8.7%) |
| Mar 2006 | - | -$16.75 M(+8.8%) |
| Dec 2005 | -$15.40 M | -$15.40 M(+4.8%) |
| Sep 2005 | - | -$14.69 M(+7.0%) |
| Jun 2005 | - | -$13.74 M(>+9900.0%) |
| Mar 2005 | - | -$129.30 K |
FAQ
- What is Cellectar Biosciences annual retained earnings?
- What is the all time high annual retained earnings for Cellectar Biosciences?
- What is Cellectar Biosciences annual retained earnings year-on-year change?
- What is Cellectar Biosciences quarterly retained earnings?
- What is the all time high quarterly retained earnings for Cellectar Biosciences?
- What is Cellectar Biosciences quarterly retained earnings year-on-year change?
What is Cellectar Biosciences annual retained earnings?
The current annual retained earnings of CLRB is -$217.48 M
What is the all time high annual retained earnings for Cellectar Biosciences?
Cellectar Biosciences all-time high annual retained earnings is -$15.40 M
What is Cellectar Biosciences annual retained earnings year-on-year change?
Over the past year, CLRB annual retained earnings has changed by -$37.98 M (-21.16%)
What is Cellectar Biosciences quarterly retained earnings?
The current quarterly retained earnings of CLRB is -$244.99 M
What is the all time high quarterly retained earnings for Cellectar Biosciences?
Cellectar Biosciences all-time high quarterly retained earnings is -$129.30 K
What is Cellectar Biosciences quarterly retained earnings year-on-year change?
Over the past year, CLRB quarterly retained earnings has changed by -$42.23 M (-20.83%)